Global Bile Duct Cancer Drug Market Report By Application (Hospitals, Clinics, And Others), Product (5-Fluorouracil, Gemcitabine, Cisplatin, Capecitabine, Oxaliplatin, And Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2019-2026

ID:VMR11210390
January 2020
Report Formats:

As per this study the Global Bile Duct Cancer Drug Market was valued USD XXX.X MN (by revenue) in 2019 and is anticipated to reach USD XXX.X MN by 2026 with a CAGR of X.XX%.

Bile duct cancer is also referred to as cholangiocarcinoma. This process involves the mutation of epithelial cells originated in the bile ducts. Basically, the bile duct is a network of the tube that connects the liver to the gall bladder in the human body. The bile duct is intended to carry a fluid called bile which is secreted in the liver and stored in the gall bladder. The primary function of bile is the breakdown of fats during digestion. The most common symptoms of bile duct cancer (cholangiocarcinoma) are abdominal pain, abnormal function of the liver, weight loss, and discoloration of stool and urine. This medical condition can also affect liver fluke infections, cholangitis, and exposure to thorium dioxide.
 
Market Dynamics
 
The global bile duct cancer drug market is mainly growing on the account of rising in the prevalence of bile duct cancer patient’s worldwide, technological innovation in terms of treatment and increasing spending’s in the health care sector. Additionally, rising research and development by pharmaceutical companies for the development of novel therapy through extensive research is also fueling market growth. Further, rising initiatives towards potential treatment for the bile duct cancer and advanced healthcare facilities is also propelling market growth. However, high cost and issues associated with the approval of drugs are acting as a major barrier to the market.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of bile duct cancer drug.
 
Market Segmentation
 
The broad bile duct cancer drug market has been sub-grouped into application and product. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Application

  • Hospitals
  • Clinics
  • Others
 
By Product
  • 5-fluorouracil
  • Gemcitabine
  • Cisplatin
  • Capecitabine
  • Oxaliplatin
  • Others
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for bile duct cancer drug in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Bile Duct Cancer Drug Market By Revenue (USD MN)
 

 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the bile duct cancer drug market include Accord Healthcare Inc., Bristol-Myers Squibb Company, Celgene Corporation, Delcath Systems Inc., Eli Lilly and Company, F. Hoffman-La Roche AG, Fresenius Kabi AG, Intercept Pharmaceuticals, Inc., Mylan N.V., Pfizer, Inc., and Teva Pharmaceuticals Industries Ltd. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Bile Duct Cancer Drug Market
       2.2. Global Bile Duct Cancer Drug Market Snapshot
 
3 . BILE DUCT CANCER DRUG – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Bile Duct Cancer Drug Market
       3.3. Market Restraints of Bile Duct Cancer Drug Market
       3.4. Opportunities of Bile Duct Cancer Drug Market
       3.5. Trends of Bile Duct Cancer Drug Market
       3.6. Porter’s Five Force Analysis of Bile Duct Cancer Drug Market
       3.7. Bile Duct Cancer Drug Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Application
           3.7.2 Market Attractive Analysis by Product
           3.7.3 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Bile Duct Cancer Drug Value Chain Analysis
       4.2. Bile Duct Cancer Drug Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Bile Duct Cancer Drug Raw Material Manufactures List
           4.2.3. Price Trend of Bile Duct Cancer Drug Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . GLOBAL BILE DUCT CANCER DRUG MARKET ANALYSIS BY APPLICATION
       5.1 Overview by Application
       5.2 Global Bile Duct Cancer Drug Market Analysis by Application
       5.3 Market Analysis of Hospitals by Regions
       5.4 Market Analysis of Clinics by Regions
       5.5 Market Analysis of Others by Regions
 
6 . GLOBAL BILE DUCT CANCER DRUG MARKET ANALYSIS BY PRODUCT
       6.1 Overview by Product
       6.2 Global Bile Duct Cancer Drug Market Analysis by Product
       6.3 Market Analysis of 5-fluorouracil by Regions
       6.4 Market Analysis of Gemcitabine by Regions
       6.5 Market Analysis of Cisplatin by Regions
       6.6 Market Analysis of Capecitabine by Regions
       6.7 Market Analysis of Oxaliplatin by Regions
       6.8 Market Analysis of Others by Regions
 
7 . GLOBAL BILE DUCT CANCER DRUG MARKET ANALYSIS BY GEOGRAPHY
       7.1. Regional Outlook
       7.2. Introduction
       7.3. North America
           7.3.1. Overview
           7.3.2. North America Bile Duct Cancer Drug Market Estimate by Market Segment
           7.3.3. North America Bile Duct Cancer Drug Market Estimate by Country
           7.3.4. United State
           7.3.5. Rest of North America
       7.4. Europe
           7.4.1. Overview
           7.4.2. Europe Bile Duct Cancer Drug Market Estimate by Market Segment
           7.4.3. Europe Bile Duct Cancer Drug Market Estimate by Country
           7.4.4. United Kingdom
           7.4.5. France
           7.4.6. Germany
           7.4.7 Rest of Europe
       7.5. Asia Pacific
           7.5.1. Overview
           7.5.2. Asia Pacific Bile Duct Cancer Drug Market Estimate by Market Segment
           7.5.3. Asia Pacific Bile Duct Cancer Drug Market Estimate by Country
           7.5.4. China
           7.5.5. Japan
           7.5.6. India
           7.5.7. Rest of Asia Pacific
       7.6. Latin America
           7.6.1. Overview
           7.6.2. Latin America Bile Duct Cancer Drug Market Estimate by Market Segment
           7.6.3. Latin America Bile Duct Cancer Drug Market Estimate by Country
           7.6.4. Brazil
           7.6.5. Rest of Latin America
       7.7. Middle East & Africa
           7.7.1. Overview
           7.7.2. Middle East & Africa Bile Duct Cancer Drug Market Estimate by Market Segment
           7.7.3. Middle East & Africa Bile Duct Cancer Drug Market Estimate by Country
           7.7.4. Middle East
           7.7.5. Africa
 
8 . COMPETITIVE LANDSCAPE OF THE BILE DUCT CANCER DRUG COMPANIES
       8.1. Bile Duct Cancer Drug Market Competition
       8.2. Partnership/Collaboration/Agreement
       8.3. Merger And Acquisitions
       8.4. New Product Launch
       8.5. Other Developments
 
9 . COMPANY PROFILES OF BILE DUCT CANCER DRUG INDUSTRY
       9.1. Company Share Analysis
       9.2. Market Concentration Rate
       9.3. Accord Healthcare Inc.
           9.3.1. Company Overview
           9.3.2. Financials
           9.3.3. Products
           9.3.4. Recent Developments
       9.4. Bristol-Myers Squibb Company
           9.4.1. Company Overview
           9.4.2. Financials
           9.4.3. Products
           9.4.4. Recent Developments
       9.5. Celgene Corporation
           9.5.1. Company Overview
           9.5.2. Financials
           9.5.3. Products
           9.5.4. Recent Developments
       9.6. Delcath Systems Inc.
           9.6.1. Company Overview
           9.6.2. Financials
           9.6.3. Products
           9.6.4. Recent Developments
       9.7. Eli Lilly and Company
           9.7.1. Company Overview
           9.7.2. Financials
           9.7.3. Products
           9.7.4. Recent Developments
       9.8. F. Hoffman-La Roche AG,
           9.8.1. Company Overview
           9.8.2. Financials
           9.8.3. Products
           9.8.4. Recent Developments
       9.9. Fresenius Kabi AG
           9.9.1. Company Overview
           9.9.2. Financials
           9.9.3. Products
           9.9.4. Recent Developments
       9.10. Intercept Pharmaceuticals, Inc.
           9.10.1. Company Overview
           9.10.2. Financials
           9.10.3. Products
           9.10.4. Recent Developments
       9.11. Mylan N.V.
           9.11.1. Company Overview
           9.11.2. Financials
           9.11.3. Products
           9.11.4. Recent Developments
       9.12. Pfizer, Inc.
           9.12.1. Company Overview
           9.12.2. Financials
           9.12.3. Products
           9.12.4. Recent Developments
       9.13. Teva Pharmaceuticals Industries Ltd.
           9.13.1. Company Overview
           9.13.2. Financials
           9.13.3. Products
           9.13.4. Recent Developments
       9.14. Others
           9.14.1. Company Overview
           9.14.2. Financials
           9.14.3. Products
           9.14.4. Recent Developments
 
10.  IMPACT ANALYSIS OF COVID-19 OUTBREAK
       10.1. Impact Analysis of Covid-19 Outbreak on the Market
           10.1.1. Direct Impact on Production
           10.1.2. Supply Chain and Market Disruption
           10.1.3. Financial Impact on Firms and Financial Markets
       10.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       10.3. Pre V/S Post COVID-19 Market
       10.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Market Size in 2020, by Scenario
       10.5. COVID-19: Micro and Macro Factor Analysis on the Market
    
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Market Snapshot
  • Drivers of the Global Market Impact Analysis
  • Restraints of the Global Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers 
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19 Market
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Market Size In 2020, By Scenario
  • COVID-19: Micro and Macro Factor Analysis on the Market
  • Global Bile Duct Cancer Drug Market Analysis by Application (USD MN)
  • Global Bile Duct Cancer Drug Market Analysis in Hospitals by Geography (USD MN)
  • Global Bile Duct Cancer Drug Market Analysis in Clinics by Geography (USD MN)
  • Global Bile Duct Cancer Drug Market Analysis in Others by Geography (USD MN)
  • Global Bile Duct Cancer Drug Market Analysis by Product (USD MN)
  • Global Bile Duct Cancer Drug Market Analysis in 5-fluorouracil by Geography (USD MN)
  • Global Bile Duct Cancer Drug Market Analysis in Gemcitabine by Geography (USD MN)
  • Global Bile Duct Cancer Drug Market Analysis in Cisplatin by Geography (USD MN)
  • Global Bile Duct Cancer Drug Market Analysis in Capecitabine by Geography (USD MN)
  • Global Bile Duct Cancer Drug Market Analysis in Oxaliplatin by Geography (USD MN)
  • Global Bile Duct Cancer Drug Market Analysis in Others by Geography (USD MN)
  • Global Bile Duct Cancer Drug Market by Geography (USD MN)
  • North America Bile Duct Cancer Drug Market Analysis by Application (USD MN)
  • North America Bile Duct Cancer Drug Market Estimate by Product (USD MN)
  • North America Bile Duct Cancer Drug Market Estimate by Country (USD MN)
  • United State Bile Duct Cancer Drug Market Analysis by Application (USD MN)
  • United State Bile Duct Cancer Drug Market Estimate by Product (USD MN)
  • Rest of North America Bile Duct Cancer Drug Market Analysis by Application (USD MN)
  • Rest of North America Bile Duct Cancer Drug Market Estimate by Product (USD MN)
  • Europe Bile Duct Cancer Drug Market Analysis by Application (USD MN)
  • Europe Bile Duct Cancer Drug Market Estimate by Product (USD MN)
  • United Kingdom Bile Duct Cancer Drug Market Analysis by Application (USD MN)
  • United Kingdom Bile Duct Cancer Drug Market Estimate by Product (USD MN)
  • France Bile Duct Cancer Drug Market Analysis by Application (USD MN)
  • France Bile Duct Cancer Drug Market Estimate by Product (USD MN)
  • Germany Bile Duct Cancer Drug Market Analysis by Application (USD MN)
  • Germany Bile Duct Cancer Drug Market Estimate by Product (USD MN)
  • Rest of Europe Bile Duct Cancer Drug Market Analysis by Application (USD MN)
  • Rest of Europe Bile Duct Cancer Drug Market Estimate by Product (USD MN)
  • Asia Pacific Bile Duct Cancer Drug Market Analysis by Application (USD MN)
  • Asia Pacific Bile Duct Cancer Drug Market Estimate by Product (USD MN)
  • Asia Pacific Bile Duct Cancer Drug Market Estimate by Country (USD MN)
  • China Bile Duct Cancer Drug Market Analysis by Application (USD MN)
  • China Bile Duct Cancer Drug Market Estimate by Product (USD MN)
  • Japan Bile Duct Cancer Drug Market Analysis by Application (USD MN)
  • Japan Bile Duct Cancer Drug Market Estimate by Product (USD MN)
  • India Bile Duct Cancer Drug Market Analysis by Application (USD MN)
  • India Bile Duct Cancer Drug Market Estimate by Product (USD MN)
  • Rest of Asia Pacific Bile Duct Cancer Drug Market Analysis by Application (USD MN)
  • Rest of Asia Pacific Bile Duct Cancer Drug Market Estimate by Product (USD MN)
  • Latin America Bile Duct Cancer Drug Market Analysis by Application (USD MN)
  • Latin America Bile Duct Cancer Drug Market Estimate by Product (USD MN)
  • Latin America Bile Duct Cancer Drug Market Estimate by Country (USD MN)
  • Brazil Bile Duct Cancer Drug Market Analysis by Application (USD MN)
  • Brazil Bile Duct Cancer Drug Market Estimate by Product (USD MN)
  • Rest of Latin America Bile Duct Cancer Drug Market Analysis by Application (USD MN)
  • Rest of Latin America Bile Duct Cancer Drug Market Estimate by Product (USD MN)
  • Middle East & Africa Bile Duct Cancer Drug Market Analysis by Application (USD MN)
  • Middle East & Africa Bile Duct Cancer Drug Market Estimate by Product (USD MN)
  • Middle East & Africa Bile Duct Cancer Drug Market Estimate by Country (USD MN)
  • Middle East Bile Duct Cancer Drug Market Analysis by Application (USD MN)
  • Middle East Bile Duct Cancer Drug Market Estimate by Product (USD MN)
  • Africa Bile Duct Cancer Drug Market Analysis by Application (USD MN)
  • Africa Bile Duct Cancer Drug Market Estimate by Product (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019
 
LIST OF FIGURES
  • Research Scope of Bile Duct Cancer Drug Report
  • Market Research Process
  • Market Research Methodology
  • Global Bile Duct Cancer Drug Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Bile Duct Cancer Drug Market Analysis by Application (USD MN)
  • Global Bile Duct Cancer Drug Market Analysis in Hospitals by Geography (USD MN)
  • Global Bile Duct Cancer Drug Market Analysis in Clinics by Geography (USD MN)
  • Global Bile Duct Cancer Drug Market Analysis in Others by Geography (USD MN)
  • Global Bile Duct Cancer Drug Market Analysis by Product (USD MN)
  • Global Bile Duct Cancer Drug Market Analysis in 5-fluorouracil by Geography (USD MN)
  • Global Bile Duct Cancer Drug Market Analysis in Gemcitabine by Geography (USD MN)
  • Global Bile Duct Cancer Drug Market Analysis in Cisplatin by Geography (USD MN)
  • Global Bile Duct Cancer Drug Market Analysis in Capecitabine by Geography (USD MN)
  • Global Bile Duct Cancer Drug Market Analysis in Oxaliplatin by Geography (USD MN)
  • Global Bile Duct Cancer Drug Market Analysis in Others by Geography (USD MN)
  • Latin America Bile Duct Cancer Drug Market by Revenue
  • Middle East & Africa Bile Duct Cancer Drug Market by Revenue
  • Recent Development in Bile Duct Cancer Drug Industry
  • Company Market Share Analysis, 2019
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials